Evidence map›Paper›PMID 30272836›Full record

Trial reportObesity (Silver Spring, Md.)2018

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).

Heather Greenlee, Danika L Lew, Dawn L Hershman, Vicky A Newman, Lisa Hansen, Sheri J Hartman, Judith Korner, Zaixing Shi, Christine L Sardo Molmenti, Antoine Sayegh and 10 more

Abstract readClinical Trial, Phase II
In one paragraph

Trial report in Obesity (Silver Spring, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Heather GreenleeMailman School of Public Health, Columbia University, New York, New York, USA.ORCID 0000-0003-4148-1405
Danika L LewSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Dawn L HershmanMailman School of Public Health, Columbia University, New York, New York, USA.
Vicky A NewmanMoores Cancer Center, University of California San Diego, La Jolla, California, USA.
Lisa HansenCompass Oncology, Rose Quarter Cancer Center, Portland, Oregon, USA.
Sheri J HartmanMoores Cancer Center, University of California San Diego, La Jolla, California, USA.
Judith KornerCollege of Physicians and Surgeons, Columbia University, New York, New York, USA.
Zaixing ShiMailman School of Public Health, Columbia University, New York, New York, USA.ORCID 0000-0001-5518-0684
Christine L Sardo MolmentiMailman School of Public Health, Columbia University, New York, New York, USA.
Antoine SayeghKaiser Permanente NCORP/ Kaiser Permanente Roseville Medical Center, Roseville, California, USA.
Lou FehrenbacherKaiser Permanente NCORP/Kaiser Permanente Medical Center, Vallejo, California, USA.
Shelly LoLoyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, Illinois, USA.
Jennifer KlempUniversity of Kansas Cancer Center, Westwood, Kansas, USA.
Kristine RinnPuget Sound Oncology Consortium/Swedish Cancer Institute, Seattle, Washington, USA.
John M RobertsonBeaumont NCORP/Beaumont Hospital, Royal Oak, Michigan, USA.
Joseph UngerSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Julie GralowSeattle Cancer Care Alliance/University of Washington, Seattle, Washington, USA.
Kathy AlbainLoyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, Illinois, USA.
Robert KrouseCorporal Michael J. Crescenz Veterans Affairs Medical Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Carol FabianUniversity of Kansas Cancer Center, Westwood, Kansas, USA.

Funding

SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
Kaiser Permanente NCI National Community Oncology Research Program, NCORPUG1CA189821 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI Jennifer Marie Suga · 2014 to 2026
$44.4M
The Pacific Cancer Research Consortium (PCRC), an NCORP Community SiteUG1CA189953 · NCI · SWEDISH MEDICAL CENTER, FIRST HILL · PI Alison Katherine Conlin, Charles Drescher · 2014 to 2026
$27.4M
NCORP of the Carolinas (Greenville Health System NCORP)UG1CA189972 · NCI · PRISMA HEALTH - UPSTATE · PI Ki Young Chung · 2014 to 2026
$17.9M
Columbia University NCI Community Oncology Research ProgramUG1CA189960 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jennifer E. Amengual, Lisa A. Kachnic · 2014 to 2026
$12.7M
National Community Oncology Research ProjectUG1CA189808 · NCI · VIA CHRISTI REGIONAL MEDICAL CENTER · PI DAKHIL, SHAKER R · 2014 to 2018
$8.6M
SWOG GRANT APPLICATION FOR LOYOLA UNIVERSITYU10CA046282 · NCI · LOYOLA UNIVERSITY CHICAGO · PI STIFF, PATRICK J · 1988 to 2013
$5.4M
SOUTHWEST ONCOLOGY GROUP CA13612U10CA013612 · NCI · UNIVERSITY OF ARIZONA · PI CRANMER, LEE D · 1985 to 2013
$4.5M
Beaumont NCI Community Oncology Research ProgramUG1CA190002 · NCI · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI ROBERTSON, JOHN M · 2014 to 2018
$4.0M
SOUTHWEST ONCOLOGY GROUP STUDIESU10CA012644 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI TAYLOR, SARAH A · 1985 to 2003
$716k
Feasibility of a weight loss intervention among female cancer survivors in SWOGR21CA155973 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GREENLEE, HEATHER · 2011 to 2013
$485k
NCI NIH HHS R21 CA155973NCI NIH HHS U10 CA012644NCI NIH HHS U10 CA013612NCI NIH HHS U10 CA046282NCI NIH HHS UG1 CA189808NCI NIH HHS UG1 CA189821NCI NIH HHS UG1 CA189953NCI NIH HHS UG1 CA189960NCI NIH HHS UG1 CA189972NCI NIH HHS UG1 CA189974NCI NIH HHS UG1 CA190002
6 · The paper itself

Abstract

objectiveThis study aimed to test the feasibility of a 12-month weight loss intervention using telephone-based counseling plus community-situated physical activity (PA) in female breast cancer (BC) and colorectal cancer (CRC) survivors.

methodsThis multisite cooperative group study enrolled sedentary, female, postmenopausal BC and CRC survivors with BMI ≥ 25 kg/m

resultsAmong 25 BC survivors, median baseline BMI was 37.2 (range: 27.7-54.6), accrual occurred in 10 months, 60% and 28% met diet and exercise goals, 80% provided 12-month measures, and average weight loss was 7.6% (95% CI: -3.9%, 19.2%). Among 23 CRC survivors, median BMI was 31.8 (range: 26.4-48.7), accrual occurred in 24 months, 61% and 17% met diet and exercise goals, 87% provided measures, and average weight loss was 2.5% (95% CI: -8.2%, 13.3%).

conclusionsIt is feasible to recruit and retain BC survivors in a cooperative group diet and PA weight loss trial. BC survivors achieved clinically meaningful weight loss but did not meet a priori adherence goals. In CRC survivors, recruitment was more difficult, and the intervention was less effective.

Indexed as

Breast NeoplasmsCancer SurvivorsColorectal NeoplasmsDietFeasibility StudiesFemaleHumansMiddle AgedObesityWeight Loss

Identifiers

PMID30272836
PMCPMC6611675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.